mesalamine and 6-thioguanylic acid

mesalamine has been researched along with 6-thioguanylic acid in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Desager, JP; Dewit, O; Horsmans, Y; Vanheuverzwyn, R1
Dilger, K; Herfarth, H; Lukas, M; Müller, R; Schaeffeler, E; Schwab, M; Strauch, U1
Baldassano, RN; Davis, CM; Hommel, KA1
Bi, HC; Chen, BL; Chen, MH; Ding, L; Gao, X; Hu, PJ; Huang, M; Liu, H; Wang, XD; Xiao, YL; Zhang, FB; Zhao, LZ1
Choe, YH; Choi, SY; Kang, B; Kim, JW; Kim, MJ; Lee, MN; Lee, SY; Woo, SY1
Andoh, A; Bamba, S; Inatomi, O; Kawahara, M; Morita, Y; Nishida, A; Sasaki, M; Sugimoto, M; Takahashi, K1

Trials

2 trial(s) available for mesalamine and 6-thioguanylic acid

ArticleYear
Interaction between azathioprine and aminosalicylates: an in vivo study in patients with Crohn's disease.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:1

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biomarkers; Crohn Disease; Drug Interactions; Female; Guanine Nucleotides; Humans; Immunosuppressive Agents; Male; Mesalamine; Methyltransferases; Middle Aged; Sulfasalazine; Thionucleotides

2002
Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
    Therapeutic drug monitoring, 2007, Volume: 29, Issue:1

    Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Monitoring; Female; Gene Frequency; Genotype; Guanine Nucleotides; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Methyltransferases; Middle Aged; Phenotype; Postoperative Period; Prospective Studies; Thioguanine; Thionucleotides; Time Factors

2007

Other Studies

4 other study(ies) available for mesalamine and 6-thioguanylic acid

ArticleYear
Medication adherence and quality of life in pediatric inflammatory bowel disease.
    Journal of pediatric psychology, 2008, Volume: 33, Issue:8

    Topics: Adolescent; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Guanine Nucleotides; Humans; Illness Behavior; Male; Medication Adherence; Mercaptopurine; Mesalamine; Quality of Life; Thionucleotides

2008
The potential influence of 5-aminosalicylic acid on the induction of myelotoxicity during thiopurine therapy in inflammatory bowel disease patients.
    European journal of gastroenterology & hepatology, 2012, Volume: 24, Issue:8

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Asian People; Azathioprine; Bone Marrow; Child; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Female; Guanine Nucleotides; Humans; Immunosuppressive Agents; Infant; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Methyltransferases; Middle Aged; Prospective Studies; Retrospective Studies; Thionucleotides; Young Adult

2012
Impact of Genetic Polymorphisms on 6-Thioguanine Nucleotide Levels and Toxicity in Pediatric Patients with IBD Treated with Azathioprine.
    Inflammatory bowel diseases, 2015, Volume: 21, Issue:12

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Female; Genotype; Guanine Nucleotides; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Leukopenia; Male; Mesalamine; Methyltransferases; Polymorphism, Genetic; Retrospective Studies; Thionucleotides

2015
pH-Dependent 5-Aminosalicylates Releasing Preparations Do Not Affect Thiopurine Metabolism.
    Digestion, 2019, Volume: 100, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Aged; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Drug Interactions; Drug Liberation; Female; Guanine Nucleotides; Humans; Hydrogen-Ion Concentration; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Middle Aged; Retrospective Studies; Thionucleotides; Time Factors; Young Adult

2019